Hefazi M, Litzow M, Hogan W, Gastineau D, Jacob E, Damlaj M, et al. ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditioning.. 2016;56(2):18.